Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
To provide a comprehensive, integrated portfolio of drug-development products and services, preclinical research and toxicology studies to support ongoing research for anticancer compound CADD522.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Charles River Laboratories | - | - | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Awarded To | Status |
|---|---|---|---|
| Lot 1 | - | Charles River Laboratories | active |